{
    "clinical_study": {
        "@rank": "156446", 
        "acronym": "COSAVEGUL-1", 
        "arm_group": [
            {
                "arm_group_label": "Upper leg vein", 
                "arm_group_type": "Active Comparator", 
                "description": "Upper leg vein harvesting"
            }, 
            {
                "arm_group_label": "Lower leg vein", 
                "arm_group_type": "Active Comparator", 
                "description": "Lower leg vein harvesting"
            }
        ], 
        "brief_summary": {
            "textblock": "In coronary artery bypass grafting, saphenous veins are widely used as a composite grafts\n      that are Y-anastomosed to in-situ left internal thoracic artery. Based on our observation\n      that remodeling of saphenous vein graft differs between those harvested from upper leg vein\n      and lower leg, this study aims to compare histologic and immunohistochemical findings\n      between saphenous vein grafts harvested from upper leg and lower leg."
        }, 
        "brief_title": "Comparison of Saphenous Vein Graft Harvested From Upper Versus Lower Leg in Coronary Artery Bypass Grafting", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Triple Vessel Disease", 
            "Unstable Angina", 
            "Stable Angina", 
            "Myocardial Infarction"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Angina Pectoris", 
                "Angina, Unstable", 
                "Infarction", 
                "Myocardial Infarction", 
                "Coronary Artery Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Inclusion criteria:\n\n        -  Patients aged from 40 to 75 years with triple vessel disease\n\n        -  Patients who are eligible for the use of left internal thoracic artery as an in situ\n           primary conduit\n\n        -  Operation plan: saphenous vein graft will be Y-anastomosed to left internal thoracic\n           artery.\n\n        -  Patients whose saphenous vein grafts can be harvested from both upper legs and lower\n           legs\n\n        -  Patients who are eligible for off-pump coronary artery bypass grafting\n\n        -  Patients who agreed with the participation in the research based on thorough\n           explanation.\n\n      Patients will be randomly assigned to upper leg vein (ULV) group and lower leg vein (LLV)\n      group immediately after anesthetic induction.\n\n      Pieces of residual saphenous vein graft will be sent for histologic and immunohistochemical\n      examination for the evaluation of endothelial cell preservation and the expression of matrix\n      proteins."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with multivessel disease who were planned to undergo off-pump coronary\n             artery bypass grafting\n\n          -  Patients whose left internal thoracic arteries can be used, and whose saphenous vein\n             grafts will be Y-anastomosed to left internal thoracic arteries.\n\n          -  Patients whose saphenous vein grafts can be harvested from both upper and lower legs.\n\n        Exclusion Criteria:\n\n          -  Patients with overt heart failure symptoms\n\n          -  Patients with intractable ventricular arrhythmia\n\n          -  Patients with history of cancer or malignancy\n\n          -  Patients with coagulation or other hematologic disorder\n\n          -  Patients who needs concomitant cardiac procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974492", 
            "org_study_id": "SNUHTS_KBKim_Saphenous"
        }, 
        "intervention": [
            {
                "arm_group_label": "Upper leg vein", 
                "description": "Patients whose saphenous veins are harvested from upper legs.", 
                "intervention_name": "Upper leg vein harvesting", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Lower leg vein", 
                "description": "Patients whose saphenous veins are harvested from lower legs.", 
                "intervention_name": "Lower leg vein harvesting", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "saphenous vein graft", 
            "composite graft", 
            "coronary artery bypass grafting", 
            "graft remodeling"
        ], 
        "lastchanged_date": "November 4, 2013", 
        "location": {
            "contact": {
                "email": "kimkb@snu.ac.kr", 
                "last_name": "Ki-Bong Kim, M.D., Ph.D.", 
                "phone": "+82-10-5326-3482"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": {
                "last_name": "Ki-Bong Kim, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Comparison of Histologic and Immunohistochemical Characteristics Between the Upper and Lower Leg Saphenous Veins Used for Coronary Artery Bypass Grafting", 
        "overall_contact": {
            "email": "sspenser@chol.com", 
            "last_name": "Hyoung Woo Chang, M.D.", 
            "phone": "+82-10-2709-5694"
        }, 
        "overall_contact_backup": {
            "email": "kimkb@snu.ac.kr", 
            "last_name": "Ki-Bong Kim, M.D., Ph.D.", 
            "phone": "+82-10-5326-3482"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Ki-Bong Kim, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Participants will be followed for the duration of hospital stay, an expected average of 1 week.", 
            "measure": "Endothelial preservation of saphenous vein graft", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974492"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Ki-Bong Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}